Wash U’s ID-CRU conducts research in several areas such as: HIV Treatment, HIV Prevention, Hepatitis and Sexually Transmitted Diseases as well as other general vaccine studies. No matter your health, age or gender we may have a study for YOU. Here are a few of the studies for which we are currently enrolling.
Reprieve is one of our most popular studies for people with HIV. It focuses on heart disease prevention and maintaining cardiovascular health.
A5324: If you are HIV+ and are interested in brain and memory health this could be the research study for you. Participants may receive medications to see if they improve mental functions such as recall, learning, and attention span.
HPTN 083 is an injectable PrEP research study, recruiting Men who have Sex with Men (U30), and Transgender Women who have Sex with Men. HPTN 083 is looking at the efficacy of Cabotegravir, a long acting injectable, compared to Truvada, the once daily pill, for HIV Prevention (PrEP). See if you qualify to participate in HPTN 083 by clicking the link below.
The ID-CRU has many more ongoing studies. Transportation and monetary compensation are often provided. These studies can be a great way to move science and healthcare forward while providing you with a chance to become engaged and informed. You will receive quality healthcare, individualized support and an opportunity to make a difference. Anyone can participate and we want you. If interested please contact us below or complete our screening survey (coming soon!) Join the movement!
To find out which studies are right for you, call us at 314-454-0058.